Title:
In silico screening of Pueraria tuberosa (PTY-2) for targeting COVID-19 by countering dual targets Mpro and TMPRSS2

dc.contributor.authorPriya Shree
dc.contributor.authorPriyanka Mishra
dc.contributor.authorPrateek Kumar
dc.contributor.authorHarsh Pandey
dc.contributor.authorRajanish Giri
dc.contributor.authorRadha Chaube
dc.contributor.authorNeha Garg
dc.contributor.authorYamini Bhusan Tripathi
dc.date.accessioned2026-02-07T11:13:51Z
dc.date.issued2022
dc.description.abstractCOVID-19 pandemic was started in Wuhan city of China in December 2019; immensely affected global population. Herein, an effort was made to identify potential inhibitors from active phytochemicals of Pueraria tuberosa (PTY-2) via molecular docking study. Our study showed five potential inhibitors (Robinin, Genistin, Daidzin, Hydroxytuberosone, Tuberostan) against Mpro and five inhibitors (Robinin, Anhydrotuberosin, Daidzin, Hydroxytuberosone, Stigmasterol) against TMPRSS2. Out of these, Robinin, Daidzin and Hydroxytuberosone were common inhibitors for Mpro and TMPRSS2. Among these, Robinin showed the highest binding affinity, therefore, tested for MD simulation runs and found stable. ADMET analysis revealed the best-docked compounds are safe and follow the Lipinski Rule of Five. Thus, it could be suggested that phytochemicals of PTY-2 could serve as potential inhibitors for COVID-19 targets. Communicated by Ramaswamy H. Sarma. © 2021 Informa UK Limited, trading as Taylor & Francis Group.
dc.identifier.doi10.1080/07391102.2021.1965029
dc.identifier.issn7391102
dc.identifier.urihttps://doi.org/10.1080/07391102.2021.1965029
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/42835
dc.publisherTaylor and Francis Ltd.
dc.subjectADMET
dc.subjectCOVID-19
dc.subjectdrug-likeness
dc.subjectM<sup>pro</sup>
dc.subjectRobinin
dc.subjectTMPRSS2
dc.titleIn silico screening of Pueraria tuberosa (PTY-2) for targeting COVID-19 by countering dual targets Mpro and TMPRSS2
dc.typePublication
dspace.entity.typeArticle

Files

Collections